baber/WOPTO huggingface dataset:
Patent FI-910774-A0 (FI)
Inventor: HAGHIRI MOHAMMAD-REZA
IPC: H04N7/26
Filed: 1991-02-18
Abstract: PCT No. PCT/NL90/00085 Sec. 371 Date Feb. 8, 1990 Sec. 102(e) Date Feb. 8, 1990 PCT Filed Jun. 19, 1990 PCT Pub. No. WO90/16128 PCT Pub. Date Dec. 27, 1990.In a signal transmission and/or storage system including a transmission stage and, after transmission and/or storage of the signals transmitted on a passband-limited information carrier which implies a processing operation for reducing the quantity of information components to be transmitted and/or stored, a receiving and/or read stage for the transmitted and/or stored signals, which arrangement for processing signals at the transmission end includes a temporal sub-sampling sub-assembly, a motion estimation sub-assembly, a recovery sub-assembly with motion compensation, a decision-taking sub-assembly, and a fall-back processing sub-assembly, with or without spatial sub-sampling. Respective signal processing arrangements provided at the receiving end correspond to these arrangements with or without the said spatial sub-sampling.
Patent FI-913892-A0 (FI)
Inventor: THOMASON ARLEN READ
IPC: C12N15/12
Filed: 1991-08-16
Abstract: Novel platelet-derived growth factor (PDGF) analogs are provided in accordance with the present invention. Also provided is a method for the production of homogeneous quantities of these novel analogs. The novel analogs of the present invention, when refolded, have substantially the same biological activity as naturally occurring PDGF B109. The method of the present invention employs the use of a stop codon on the c-sis gene, or other coding sequence for a precursor protein of PDGF B109, or analogs thereof, at a position corresponding to a location from about amino acid 111 to about amino acid 160. The method of the present invention results in the production of relatively large homogeneous quantities of recombinant PDGF B analogs from high expression host cells, such as E. coli.
Patent FI-924336-A0 (FI)
Inventor: SMITH STEVEN DARYL
IPC: A61K6/00
Filed: 1992-09-28
Abstract: Cationic ammonium-substituted vinyl polymer is used to improve the performance properties of various adhesives. Adhesives such as the alkyl vinyl ether/maleic acids and various other polymeric adhesives exhibit improved holding properties when combined with the ammonium-substituted polymer, especially in the presence of moisture. Improved bioadhesives, e.g., denture adhesives, are provided.
Patent FI-925731-A0 (FI)
Inventor: NEUSTADT BERNARD R
IPC: A61K31/522
Filed: 1992-12-17
Abstract: PCT No. PCT/US91/04154 Sec. 371 Date Dec. 14, 1992 Sec. 102(e) Date Dec. 14, 1992 PCT Filed Jun. 20, 1991 PCT Pub. No. WO91/19717 PCT Pub. Date Dec. 26, 1991.Novel polycylic guanine derivatives of the formula:    <IMAGE>  (I)  and   <IMAGE>  (I')  wherein J is oxygen or sulfur, R1 is hydrogen, alkyl or alkyl substituted with aryl or hydroxy; R2 is hydrogen, aryl, heteroaryl, cycloalkyl, alkyl or alkyl substituted with aryl, heteroaryl, hydroxy, alkoxy, amino, monoalkyl amino or dialkylamino, or -(CH2)mTCOR20 wherein m is an integer from 1 to 6, T is oxygen or -NH- and R20 is hydrogen, aryl, heteroaryl, alkyl or alkyl substituted with aryl or heteroaryl; R3 is hydrogen, halo, trifluoromethyl, alkoxy, alkylthio, alkyl, cycloalkyl, aryl, aminosulfonyl, amino, monoalkylamino, dialkylamino, hydroxyalkylamino, aminoalkylamino, carboxy, alkoxycarbonyl or aminocarbonyl or alkyl substituted with awl, hydroxy, alkoxy, amino, monoalkylamino or dialkylamino; Ra, Rb, Rc, and Rd are defined in the specification; and n is zero or one. The compounds of formulas (I) and (I') are useful as antihypertensive, muscle relaxant and bronchodilating agents.
Patent FI-933206-A0 (FI)
Inventor: MASAKI MITSUO
IPC: C07D233/36
Filed: 1993-07-14
Abstract: Disclosed are new alkylenediamine derivatives of the following formula which are effective for treatment of dysuria are disclosed: <CHEM> wherein R<1> is hydrogen, alkyl, or a substituted or unsubstituted phenyl, naphthyl or aromatic heterocyclic group; R<2> is a substituted or unsubstituted phenyl, naphthyl or aromatic heterocyclic group; R<3> and R<4> represent hydrogen, alkyl, aralkyl or aryl; or R<3> and R<4> are combined to form one of substituted or unsubstituted 5- to 7-membered heterocyclic groups; X is oxygen, sulfur or imino; Y is oxygen or sulfur; Z is -CH2-, -CO- or -CS-; m is an integer of 0-4; n is an integer of 0-4; r is 0 or 1; and p and q represent an integer of 0-5 provided that p plus q is 1-5.
Patent FI-945501-A0 (FI)
Inventor: HAGSTROEM ULF ERLING
IPC: H04W88/08
Filed: 1994-11-23
Abstract: In a radio communications system having at least one base station, the base station including a plurality of transceivers, a control method and apparatus includes the steps of comparing the number of transceivers in a call state to a first predefined number. If the number of call state transceivers is greater than the first predefined number, then all of the idle transceivers except at least one are switched off. If the number of call state transceivers is less than the first predefined number, then all excess idle transceivers are switched off. Also, after switching off the first subset of the plurality of transceivers, a second subset may be switched off after waiting a predetermined time period. The number of operational transceivers in the second subset is less than in the first subset. To further reduce the power consumption of the base station, a first group of radio communications system subscribers is designated as a high priority group, and a second group of subscribers is designated as a low priority group. The system is designed to grant service to the high priority group, while denying it to the low priority group. The control methods and apparatus are useful, for example, for reducing power consumption and/or traffic handling capacity of a base station.
Patent FI-950622-A0 (FI)
Inventor: ANDERSSON KJELL
IPC: D21H17/67
Filed: 1995-02-13
Abstract: PCT No. PCT/SE93/00663 Sec. 371 Date Feb. 3, 1995 Sec. 102(e) Date Feb. 3, 1995 PCT Filed Aug. 11, 1993 PCT Pub. No. WO94/05596 PCT Pub. Date Mar. 17, 1994Silica sols with a high content of microgel and particles with a specific surface area within the range 300 to 700 m2/g, preferably 400 to 650 m2/g. The sols can be prepared by acidification or a water glass solution and alkalization at a certain dry content, alternatively to a certain pH. The sols are particularly suitable for use as additives in papermaking in combination with cationic polymers and especially in combination with cationic acrylamide based polymers.
Patent FI-953821-A0 (FI)
Inventor: LINDGREN ERIK
IPC: D21H17/17
Filed: 1995-08-11
Abstract: The present invention generally relates to a method for reducing the content of organic solvent in an aqueous dispersion of a cellulose-reactive hydrophobing agent, prepared by emulsifying a molten cellulose-reactive hydrophobing agent containing organic solvent in an aqueous solution containing one or more emulsifying agents. The method comprises contacting the aqueous dispersion under agitation with a sorbent, said sorbent having the capacity of absorbing organic molecules, or a gas, whereby the solvent is transferred to the sorbent or the gas.
Patent FI-955424-A0 (FI)
Inventor: SZENTE LAJOS
IPC: A61K47/48
Filed: 1995-11-10
Abstract: The present invention relates to an active inclusion complex of Taxol, Taxotere or a Taxus extract formed with a cyclodextrin-derivative, a pharmaceutical composition containing the same, a process of preparation and a method of treatment.
Patent FI-960836-A0 (FI)
Inventor: SEMPLE GRAEME
IPC: C07D403/04
Filed: 1996-02-23
Abstract: PCT No. PCT/GB94/01859 Sec. 371 Date May 2, 1996 Sec. 102(e) Date May 2, 1996 PCT Filed Aug. 25, 1994 PCT Pub. No. WO95/06040 PCT Pub. Date Mar. 2, 1995A benzodiazepine derivative of formula I, or a pharmaceutically acceptable salt thereof:    <IMAGE>  I  wherein: (a) R4 is an alkyl, cycloalkyl or aryl group. (b) R10 is chosen from halo, OH, CH3, OCH3, NR11R12, NO2, NHCHO, CO2H and CN, and R11 and R12 are independently selected from H and alkyl (C1-C5) or together NR11R12 form a cyclic structure II,    <IMAGE>  II  wherein a is 1-6; and (c) R2 is an aromatic 5- or 6-membered, substituted or unsubstituted heterocycle containing at least two heteroatoms of which at least one is nitrogen. These compounds are gastrin and/or CCK-B receptor antagonists.
Patent FI-963860-A0 (FI)
Inventor: LILJESTROEM PETER
IPC: A61P35/00
Filed: 1996-09-27
Abstract: The present invention is related to polynucleotide molecules and to their use for production of desired products after introduction into human or animal cells. In addition, the present invention is concerned with pharmaceutical compositions comprising said polynucleotide molecules and their use in prophylactic or therapeutic treatment methods. The present invention is also related to use of such polynucleotide molecules in animals to achieve expression of desired products, which can be recovered from the animal but do not give rise to any beneficial, e.g. therapeutic, activity in the animal. More specifically, the present invention is directed to alphaviruus cDNA vectors comprised of recombinant cDNA consisting of cDNA derived from an alphavirus and heterologous, i.e. foreign, cDNA encoding a desired substance.
Patent FI-972727-A0 (FI)
Inventor: BOREALIS AS
IPC: C08F2/00
Filed: 1997-06-24
Abstract: Described herein is a process for preparing propylene copolymers. The process comprises the steps of polymerizing propylene with comonomers in at least one slurry reactor and at least one gas phase reactor, at least 10 % of the polymer product being produced in the gas phase reactor(s); recovering from the slurry reactor a copolymerization product containing unreacted monomers and conducting the copolymerization product to a first gas phase reactor essentially without recycling of the unreacted monomers to the slurry reactor before the gas phase reactor. The process will provide high randomness copolymers, which are very soft. <IMAGE>
Patent IL-67672-A0 (IL)
Title: Penicillin derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/43
Filed: 1983-01-12
Abstract: Preparation and use of 6,alpha-methoxy-6,beta-2-(2-methylphenoxycarbonyl)-2-(thien-3-yl) acetamido penicillanic acid of the formula 
<CHEM>
 or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. 
<??>Intermediate of formula (X) 
<CHEM>
 and pharmaceutical composition comprising a penicillin of the first-mentioned formula, optionally with a clavulanic-acid derivative.
Patent IL-71664-A0 (IL)
Title: Fluoroalkoxy compounds,process for their preparation,and pharmaceutical composition containing the same
IPC: A61K31/4402
Filed: 1984-04-27
Abstract: Fluoroalkoxy compounds of the general formula I    <IMAGE>  (I) wherein R1 represents a 1-3C-alkyl radical which is completely or predominantly substituted by fluorine, or a chlorodifluoromethyl radical, R1' represents hydrogen, halogen, trifluoromethyl, a 1-3C-alkyl radical, or a 1-3C-alkoxy radical which is optionally completely or predominantly substituted by fluorine, R2 represents hydrogen or a 1-3C-alkyl radical, R3 represents hydrogen or a 1-3C-alkyl or 1-3C-alkoxy radical, R4 represents hydrogen or a 1-3C-alkyl radical and n represents the number 0 or 1, and their salts are new compounds with a marked protective effect on the stomach.
Patent IL-79385-A0 (IL)
Title: Absorber for nuclear radiations
IPC: C22C21/00
Filed: 1986-07-10
Abstract: 1. An absorber for nuclear radiations characterised in that it is formed by an alloy of gadolinium with an aluminium selected from the group comprising pure aluminium, alloyed aluminium and pure or alloyed aluminium containing a dispersed phase.
Patent IL-83971-A0 (IL)
Title: Recombinant pseudomonas exotoxins:construction of an active immunotoxin with low side effects
IPC: C12N15/09
Filed: 1987-09-22
Abstract: The present invention relates to various modified forms of Pseudomonas exotoxin exhibiting low toxicity to human or animal cells by itself but retaining its enzymatic activity. The modified Pseudomonas exotoxin of the present invention has ADP ribosylating activity but lacks all or part of domain II (responsible for translocation across cell membrane) of the native toxin. A preferred modified Pseudomonas exotoxin of the present invention further comprises a modification in the receptor binding domain IA of the native Toxin. Conjugates (immunotoxins) comprising a modified Pseudomonas exotoxin and a targeting carrier, such as an antibody or a growth factor, methods for producing a modified Pseudomonas exotoxin or conjugates thereof and compositions suitable for administration to a mammal for achieving targeted cytotoxin activity are also disclosed.
Patent IL-84062-A0 (IL)
Title: Diamine-platinum(ii)complex compounds having a hydroxylated 2-phenylindole ring,their preparation and pharmaceutical compositions containing them
IPC: A61P35/00
Filed: 1987-10-01
Abstract: 1. Claims for the contracting States BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Cis-platinum complexes of the general formula   see diagramm : EP0262498,P18,F5   wherein R1 denotes hydrogen, a hydroxyl group or a C2 -C6 - alkanoyloxy group, R2 denotes hydrogen or a halogen atom, R3 denotes hydrogen or a C1 -C6 -alkyl group, R4 denotes a hydroxyl group or a C2 -C6 -alkanoyloxy group, R5 denotes hydrogen or a halogen atom and R6 denotes hydrogen or a halogen atom, Alk represents a C2 -C10 -alkylene chain, where 4 adjacent CH2 groups may furthermore be replaced by a 1,4-phenylene ring,   see diagramm : EP0262498,P18,F6   denotes the group   see diagramm : EP0262498,P18,F7     see diagramm : EP0262498,P18,F8   or   see diagramm : EP0262498,P19,F1   and R7 is a hydrogen atom, a C1 -C6 -alkyl group or a phenyl radical and X represents one equivalent of a physiologically tolerated anion. 1. Claims for the contracting States AT, ES, GR Process for the preparation of cis-platinum complexes of the general formula   see diagramm : EP0262498,P20,F1   wherein R1 denotes hydrogen, a hydroxyl group or a C2 -C6 -alkanoyloxy group, R2 denotes hydrogen or a halogen atom, R3 denotes hydrogen or a C1 -C6 -alkyl group, R4 denotes a hydroxyl group or a C2 -C6 -alkanoyloxy group, R5 denotes hydrogen or a halogen atom and R6 denotes hydrogen or a halogen atom, Alk represents a C2 -C10 -alkylene chain, where 4 adjacent CH2 groups may furthermore be replaced by a 1,4-phenylene ring,   see diagramm : EP0262498,P20,F2   denotes the group   see diagramm : EP0262498,P20,F3     see diagramm : EP0262498,P20,F4   or   see diagramm : EP0262498,P20,F5   and R7 is a hydrogen atom, a C1 -C6 -alkyl group or a phenyl radical and X represents one equivalent of a physiologically tolerated anion, characterised in that a tetrahaloplatinum (II) acid, a tetrahaloplatinum (II) complex salt having two monovalent cations or one divalent cation or a platinum(II) halide is reacted with a compound of the formula   see diagramm : EP0262498,P20,F6   or a salt of the compound II, wherein the radicals R1 , R2 , R3 , R4 , R5 and R6 and the groups Alk and A-B have the stated meanings, and, if required, the radical X or the radicals X in a resulting compound of the formula I is or are exchanged for other physiologically tolerated anions.
Patent IL-90013-A0 (IL)
Title: Chromium electroplating bath
IPC: C25D3/10
Filed: 1989-04-18
Abstract: Bright and smooth functional chromium is deposited using a plating bath containing chromic acid, 40-150 g/l sulfoacetic acid, an iodine-releasing agent e.g. - iodate, and a nitrogen organic compound e.g. glycine as a depolariser. The bath is otherwise free of carboxylic acids, fluoride, bromide and selenium ions. The process can be operated at conventional plating current densities e.g. 1-10 asi:.
Patent IL-91024-A0 (IL)
Title: Peptide and dna sequences
IPC: C12R1/645
Filed: 1989-07-18
Abstract: Secretory leader sequences, for use in secreting heterologous polypeptides in yeast, are formed by fusing part of the human serum albumin pre-sequence or part of the Kluyveromyces lactis killer toxin pre-sequence to the Saccharomyces cerevisiae mating factor alpha-1 KEX2 cleavage recognition site. The resulting fusion leader sequences are: (a) H2N-Met-Lys-Trp-Val-Ser-Phe-Ile-Ser-Leu-Leu-Phe-Leu-Phe-Ser-Ser-Ala-Tyr-Ser-Arg-Ser-Leu-Asp-Lys-Arg-COOH or (b) H2N-Met-Asn-Ile-Phe-Tyr-Ile-Phe-Leu-Phe-Leu-Leu-Ser-Phe-Val-Gln-Gly-Ser-Leu-Asp-Lys-Arg-COOH Conservative variations are also encompassed.
Patent FI-20050257-A0 (FI)
Inventor: SAHLBERG TEPPO
IPC: B32B38/06
Filed: 2005-03-09
Abstract: The invention relates to a method for producing a visually identifiable diffractive pattern on a substrate by subjecting the substrate to pressure by bringing it into contact with a surface of an embossing plate. An imprinted paper or paperboard sheet, which is varnished at the contacting area of the embossing plate and the substrate is used as a substrate for the embossing. The invention relates also to a product manufactured using the described method. The method is applicable, for example, for common packaging materials, which contain a paperboard, imprinting and a varnish layer for producing a visually attractive and unique marking.
Patent FI-20065735-A0 (FI)
Inventor: KOSKI SALLA
IPC: G16H40/60
Filed: 2006-11-20
Abstract: A user portable measurement device (100) includes a measurement unit (174) for measuring and monitoring human health information, a user interface (175) for presenting information based on a measurement result, elements for storing information relating to the care of the user (173), and elements for forming activity instructions on the basis of the care information and at least one measurement result. The user interface (175) of the measurement device (100) preferably includes a display for presenting characters and/or symbols and elements for forming a tone and/or speech. The device is especially suitable for e.g. monitoring and care of overweight and diabetes. A system having many user devices and a server for acquisition and storage of the measurement data is also described. The server may further be used to provide an access to game or chat program services to motivate or help individual users of the measurement devices.
Patent IL-101373-A0 (IL)
Title: Azadecalin amides and thioamides as inhibitors of cholesterol biosyntheses
IPC: A61P31/10
Filed: 1992-03-25
Abstract: Compounds of the formula <CHEM>  wherein     E   is O or S; G   is A-Y-B-D, A-Y-D, A-D or D1 wherein A   is a saturated C1-C14 alkylene of straight or branched chain cornfiguarion; Y   is oxygen, sulfur, sulfinyl or sulfonyl; B   is a saturated C1-C14 alkylene of straight or branched chain configuration; D   is a C1-C4 saturated or unsaturated alkyl of straight or branched chain configuration, -CF3, -CHF2, -CH2F, or phenyl; and D1   is H, -CF3, -CHF2, -CH2F, -CH3 or phenyl. are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
Patent IL-105148-A0 (IL)
Title: Process for improving water-whitening resistance of coatings
IPC: C09J11/00
Filed: 1993-03-24
Abstract: A process is disclosed for improving the water-whitening resistance of a pressure sensitive adhesive containing an aqueous latex emulsion and water-soluble ions by removing the water-soluble ions and adjusting the pH of the pressure sensitive adhesive formulation to at least about 6.0. The preferred method of removing the water-soluble ions is to contact either the aqueous latex emulsion, the formulated pressure sensitive adhesive containing the aqueous latex emulsion, or both with ion exchange resin. The product produced by the process is also disclosed.
Patent IL-117199-A0 (IL)
Title: Metal complexes of diethylenetriamine-pentaacetic acid monoamide derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
IPC: A61P1/16
Filed: 1996-02-20
Abstract: The invention relates to diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, containing an element of atomic numbers 20-32, 39-51 or 57-83, pharmaceutical agents containing these compounds, their use as contrast media and antidotes and process for their production.
Patent IL-120968-A0 (IL)
Title: Process for producing N-(D-alpha-methyl-beta-mercaptopropionyl)-L-proline and its intermediates
IPC: A61K31/00
Filed: 1996-10-07
Abstract: A highly convenient and efficient process for economically producing in a high yield high-quality captopril which is remarkably reduced in the content of impurities and has a high melting point and intermediates for synthesizing the same which contain only a small amount of precursors as impurities and have excellent qualities. The process comprises subjecting an acid halide and an L-proline to the Schotten-Baumann reaction and eliminating the impurities formed as the by-products in the form of the precursors represented by general formula (5) or (6) by treating, during or after the Schotten-Baumann reaction, the aqueous medium solution with active carbon or crystallization followed by deacylation. In the formula, R<1> represents acyl and n represents an integer of from 2 to 4. <CHEM>
Patent IL-122279-A0 (IL)
Title: Polymerizable siloxane macromonomers
IPC: G02B1/04
Filed: 1996-06-04
Abstract: PCT No. PCT/EP96/02421 Sec. 371 Date Mar. 9, 1998 Sec. 102(e) Date Mar. 9, 1998 PCT Filed Jun. 4, 1996 PCT Pub. No. WO97/00274 PCT Pub. Date Jan. 3, 1997A macromonomer of the formula I is described:Q-B(L-B)nT(I)wherein n is zero or at least 1.0; Q is a polymerizable group; B may be the same or different and is a difunctional block of molecular weight in the range of from 100 to 8000 and wherein at least one B is a residue from a difunctional polymer or copolymer wherein B has a molecular weight of 248 to 8000 comprising silicone repeat units of formula II  where R1 and R2 may be the same or different and are selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, aryl, haloalkyl, haloalkenyl, haloalkynyl, haloaryl, heterocyclyl and haloheterocyclyl; L is a difunctional linking group; and T is a terminal group. The macromonomer may be used preferably in the production of contact lenses.
Patent IL-126324-A0 (IL)
Title: A method and apparatus for client managed flow control on a limited memory computer system
IPC: G06F9/50
Filed: 1997-03-14
Abstract: A method and apparatus for controlling data flow on a network having a server and a non-blocking client node in which the client node may not drop requests received from the server. A process on the non-blocking client node allocates resources on the non-blocking client node and notifies the server of the allocated resources. The server then determines the resources on the non-blocking client node required to fulfill a request by an application on the server and whether sufficient resources are available on the non-blocking client node to fulfill the request by the application. If sufficient resources are available, the server then sends the request to the client node and if sufficient resources do not exist, the server waits until sufficient resources do exist to issue the request to the non-blocking client node.
Patent IL-130418-A0 (IL)
Title: Panel-form loudspeaker
IPC: H04R1/02
Filed: 1997-12-08
Abstract: To overcome acoustic distortion caused by local resonance in panel core cells, a resonant multi-mode radiator element is provided for a panel form loudspeaker with a functional upper frequency limit ƒmax. The element has skins and a cellular based core, the skins have a thickness h, a Young's modulus Ε a Poisson's ratio of ν and a material density rho and the core has a cell size lcell characterized in that the cell size lcell is less than equation (2).